lidocaine has been researched along with Fibromyalgia in 32 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of 240 mg of intravenous lidocaine (once a week for 4 weeks) with 25 mg of amitriptyline for 8 weeks had no meaningful impact in fibromyalgia patients." | 9.22 | Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study. ( Albertoni Giraldes, AL; Brunialti, MK; Leal, PD; Sakata, RK; Salomão, R, 2016) |
| "Combined administration of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or plasma serotonin, norepinephrine, or dopamine concentrations in fibromyalgia patients." | 9.15 | Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. ( Issy, AM; Sakata, RK; Vlainich, R, 2011) |
| "To assess the efficacy of 4% topical lidocaine in spheno-palatine blocks, a randomized controlled trial was carried out on patients with chronic muscle pain syndromes." | 9.08 | The use of topical 4% lidocaine in spheno-palatine ganglion blocks for the treatment of chronic muscle pain syndromes: a randomized, controlled trial. ( Delaney, G; Heck, C; Janzen, V; McCain, GA; Russell, AL; Scudds, RA; Teasell, RW; Varkey, G; Woodbury, GM, 1995) |
| "Pain intensity, muscle strength, static muscle endurance, pressure pain threshold, and pain tolerance at tender points and control points were assessed in 31 patients with fibromyalgia (FM), before and after intravenous administration of morphine (9 patients), lidocaine (11 patients), and ketamine (11 patients)." | 9.08 | Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. ( Bäckman, E; Bengtsson, A; Bengtsson, M; Henriksson, KG; Sörensen, J, 1995) |
| "To determine the effect of escalating doses of lidocaine infusion with or without added magnesium on pain levels and the duration of pain relief in patients with fibromyalgia (FM)." | 7.96 | Repeated Intravenous Lidocaine Infusions for Patients with Fibromyalgia: Higher Doses of Lidocaine Have a Stronger and Longer-Lasting Effect on Pain Reduction. ( Perelman, VS; Pugacheva, O; Voznyak, Y; Wansbrough, MCT; Wilderman, I; Zolnierczyk, L, 2020) |
| "Primary mechanical hyperalgesia at the shoulders and buttocks decreased significantly more after lidocaine than saline injections (p = 0." | 6.79 | Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. ( Bartley, E; Price, DD; Robinson, ME; Staud, R; Weyl, EE, 2014) |
| "Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire, and a visual analog scale (VAS) for pain were applied before the first lidocaine infusion, immediately after the fifth infusion and 30 days after the fifth infusion." | 6.74 | Intravenous lidocaine for fibromyalgia syndrome: an open trial. ( Harth, F; Kaiber, F; Machado, F; Malucelli, T; Schafranski, MD; Schmidt, C; Takeshi, H, 2009) |
| "To compare the analgesic effect of anesthetic infiltration of lidocaine 2% and low-level laser therapy (LLLT) by GaAlAs into tender points of patients with orofacial pain and fibromyalgia (FM)." | 5.27 | Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial. ( de Oliveira E Silva, EM; de Sousa, ET; de Souza, RC; Gomes, AC; Limeira-Junior, FA; Meira, UM; Scudine, KG, 2018) |
| "The combination of 240 mg of intravenous lidocaine (once a week for 4 weeks) with 25 mg of amitriptyline for 8 weeks had no meaningful impact in fibromyalgia patients." | 5.22 | Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study. ( Albertoni Giraldes, AL; Brunialti, MK; Leal, PD; Sakata, RK; Salomão, R, 2016) |
| "Combined administration of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or plasma serotonin, norepinephrine, or dopamine concentrations in fibromyalgia patients." | 5.15 | Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. ( Issy, AM; Sakata, RK; Vlainich, R, 2011) |
| "Lidocaine injections increased local pain thresholds and decreased remote secondary heat hyperalgesia in FM patients, emphasizing the important role of peripheral impulse input in maintaining central sensitization in this chronic pain syndrome; similar to other persistent pain conditions such as irritable bowel syndrome and complex regional pain syndrome." | 5.14 | Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. ( Nagel, S; Price, DD; Robinson, ME; Staud, R, 2009) |
| "To assess the efficacy of 4% topical lidocaine in spheno-palatine blocks, a randomized controlled trial was carried out on patients with chronic muscle pain syndromes." | 5.08 | The use of topical 4% lidocaine in spheno-palatine ganglion blocks for the treatment of chronic muscle pain syndromes: a randomized, controlled trial. ( Delaney, G; Heck, C; Janzen, V; McCain, GA; Russell, AL; Scudds, RA; Teasell, RW; Varkey, G; Woodbury, GM, 1995) |
| "Pain intensity, muscle strength, static muscle endurance, pressure pain threshold, and pain tolerance at tender points and control points were assessed in 31 patients with fibromyalgia (FM), before and after intravenous administration of morphine (9 patients), lidocaine (11 patients), and ketamine (11 patients)." | 5.08 | Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. ( Bäckman, E; Bengtsson, A; Bengtsson, M; Henriksson, KG; Sörensen, J, 1995) |
| "To determine the effect of escalating doses of lidocaine infusion with or without added magnesium on pain levels and the duration of pain relief in patients with fibromyalgia (FM)." | 3.96 | Repeated Intravenous Lidocaine Infusions for Patients with Fibromyalgia: Higher Doses of Lidocaine Have a Stronger and Longer-Lasting Effect on Pain Reduction. ( Perelman, VS; Pugacheva, O; Voznyak, Y; Wansbrough, MCT; Wilderman, I; Zolnierczyk, L, 2020) |
| "Primary mechanical hyperalgesia at the shoulders and buttocks decreased significantly more after lidocaine than saline injections (p = 0." | 2.79 | Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. ( Bartley, E; Price, DD; Robinson, ME; Staud, R; Weyl, EE, 2014) |
| "Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire, and a visual analog scale (VAS) for pain were applied before the first lidocaine infusion, immediately after the fifth infusion and 30 days after the fifth infusion." | 2.74 | Intravenous lidocaine for fibromyalgia syndrome: an open trial. ( Harth, F; Kaiber, F; Machado, F; Malucelli, T; Schafranski, MD; Schmidt, C; Takeshi, H, 2009) |
| "Ten patients with primary fibromyalgia syndrome were treated with intravenous infusions of lignocaine on a daily basis for six days." | 2.68 | Intravenous lignocaine in the management of primary fibromyalgia syndrome. ( Bennett, MI; Tai, YM, 1995) |
| "Pain was analyzed in patients with fibromyalgia (FM) in a randomized, double blind, crossover study using intravenous (i." | 2.68 | Fibromyalgia--are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. ( Ahlner, J; Bengtsson, A; Bengtsson, M; Ekselius, L; Henriksson, KG; Sörensen, J, 1997) |
| "Enhanced somatic pains are accompanied by mechanical hyperalgesia and allodynia in FM patients as compared with healthy controls." | 2.46 | Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. ( Staud, R, 2010) |
| "Primary fibromyalgia is a common but often unrecognized rheumatic condition." | 1.26 | Primary fibromyalgia. ( Calabro, JJ; Masi, AT; Shah, IK; Yunus, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.88) | 18.7374 |
| 1990's | 10 (31.25) | 18.2507 |
| 2000's | 4 (12.50) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Wilderman, I | 1 |
| Pugacheva, O | 1 |
| Perelman, VS | 1 |
| Wansbrough, MCT | 1 |
| Voznyak, Y | 1 |
| Zolnierczyk, L | 1 |
| Rezasoltani, Z | 1 |
| Ehyaie, H | 1 |
| Mofrad, RK | 1 |
| Vashaei, F | 1 |
| Mohtasham, R | 1 |
| Najafi, S | 1 |
| de Souza, RC | 1 |
| de Sousa, ET | 1 |
| Scudine, KG | 1 |
| Meira, UM | 1 |
| de Oliveira E Silva, EM | 1 |
| Gomes, AC | 1 |
| Limeira-Junior, FA | 1 |
| Niraj, G | 1 |
| Staud, R | 3 |
| Weyl, EE | 1 |
| Bartley, E | 1 |
| Price, DD | 2 |
| Robinson, ME | 2 |
| Albertoni Giraldes, AL | 1 |
| Salomão, R | 1 |
| Leal, PD | 1 |
| Brunialti, MK | 1 |
| Sakata, RK | 2 |
| Moon, JJ | 1 |
| Ahn, MW | 1 |
| Ahn, HS | 1 |
| Lee, SJ | 1 |
| Lee, DY | 1 |
| Schafranski, MD | 1 |
| Malucelli, T | 1 |
| Machado, F | 1 |
| Takeshi, H | 1 |
| Kaiber, F | 1 |
| Schmidt, C | 1 |
| Harth, F | 1 |
| Nagel, S | 1 |
| Geber, C | 1 |
| Vlainich, R | 1 |
| Issy, AM | 1 |
| Furuta, A | 1 |
| Suzuki, Y | 1 |
| Honda, M | 1 |
| Koike, Y | 1 |
| Naruoka, T | 1 |
| Asano, K | 1 |
| Chancellor, M | 1 |
| Egawa, S | 1 |
| Yoshimura, N | 1 |
| Raphael, JH | 1 |
| Southall, JL | 1 |
| Kitas, GD | 1 |
| GALLETTI, R | 1 |
| PROCACCI, P | 1 |
| MARCHETTI, PG | 1 |
| ROCCHI, P | 1 |
| BUZZELLI, G | 1 |
| Ga, H | 1 |
| Koh, HJ | 1 |
| Choi, JH | 1 |
| Kim, CH | 1 |
| Yunus, M | 1 |
| Masi, AT | 1 |
| Calabro, JJ | 1 |
| Shah, IK | 1 |
| Scudds, RA | 1 |
| Janzen, V | 1 |
| Delaney, G | 1 |
| Heck, C | 1 |
| McCain, GA | 1 |
| Russell, AL | 1 |
| Teasell, RW | 1 |
| Varkey, G | 1 |
| Woodbury, GM | 1 |
| Bassan, H | 1 |
| Niv, D | 1 |
| Jourgenson, U | 1 |
| Wientroub, S | 1 |
| Spirer, Z | 1 |
| Sörensen, J | 3 |
| Bengtsson, A | 2 |
| Bäckman, E | 1 |
| Henriksson, KG | 2 |
| Bengtsson, M | 2 |
| Kosek, E | 1 |
| Ekholm, J | 1 |
| Hansson, P | 2 |
| Paulson, GW | 1 |
| Gill, W | 1 |
| Bennett, MI | 1 |
| Tai, YM | 1 |
| Hong, CZ | 1 |
| Hsueh, TC | 1 |
| Ahlner, J | 1 |
| Ekselius, L | 1 |
| Janzen, VD | 1 |
| Scudds, R | 1 |
| Arnér, S | 1 |
| Gustafsson, L | 1 |
| Kinnman, E | 1 |
| Sollevi, A | 1 |
| Crile, G | 1 |
| Annexton, M | 1 |
| Coulehan, JL | 1 |
| Kraus, H | 1 |
| Trojaborg, W | 1 |
| Rowland, LP | 1 |
| Katz, RI | 1 |
| Wheaton, EA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic[NCT04043624] | Phase 4 | 80 participants (Anticipated) | Interventional | 2019-08-01 | Recruiting | ||
| What Determines a Positive Outcome of Spinal Manipulation for Persistent Low Back Pain: Stiffness or Pain Sensitivity? A Randomized Trial[NCT04086667] | 132 participants (Actual) | Interventional | 2017-11-01 | Completed | |||
| Dry Needling in Patients With Fibromyalgia: Analysis of Its Therapeutic Effectiveness[NCT04942444] | 120 participants (Anticipated) | Interventional | 2011-01-10 | Recruiting | |||
| Double-blind, Prospective Comparison of Medications Used in Trigger Point Injections - Ketorolac, Lidocaine, or Dexamethasone[NCT03028012] | Phase 4 | 10 participants (Actual) | Interventional | 2017-05-02 | Terminated (stopped due to Poor enrollment.) | ||
| Nitrous Oxide as Treatment for Fibromyalgia[NCT05357066] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-11-12 | Recruiting | ||
| Evaluation of the Efficiency of a Therapeutic Education Program in Standardized Thermal Cure for Fibromyalgia Patients[NCT02406313] | 152 participants (Actual) | Interventional | 2015-03-31 | Active, not recruiting | |||
| Treating Trigger Points: Comparing Muscle Energy Technique vs. Lidocaine Needling Technique for Pain Control and Quality of Life Measurements[NCT05009264] | 32 participants (Actual) | Observational | 2022-01-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Participants in this study underwent TPIs by the following method. The needle was inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. This was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain, one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Post Injections Up to Three Months
| Intervention | Participants (Count of Participants) |
|---|---|
| Ketorolac | 1 |
| Lidocaine | 0 |
| Dexamethasone | 0 |
The BPI was evaluated on a scale from 0-10. Zero would mean no interference and 10 would be calculated at complete interferences. We used a 7-point questionnaire about pain. All scores were calculated at baseline and three months. (NCT03028012)
Timeframe: Baseline and Three Months
| Intervention | score on a scale (Number) | |||
|---|---|---|---|---|
| Participant Number #3 at Baseline | Participant Number #3 at 3 Months | Participant Number #8 at Baseline | Participant #8 at 3 Months | |
| Ketorolac | 8 | 3 | 5 | 3 |
TPI were treated with a needle inserted into the trigger point with the goal of eliciting a local twitch responses(LTRs). When a LTR was obtained, 0.1mL of randomized drug was injected into that location within the muscle. This was repeated until LTRs disappeared, or 1.0mL had been injected, whichever came first. Such was performed in a similar manner for all affected muscles, up to a maximum of 2mL. Participants self-report their brief pain inventory at each of their injections (up to four subsequent injections) based off of the standardized Numeric Rating pain Scale (NRS). The NRS is nationally recognized numeric scale from zero to ten, with zero being an example of no pain,one to three would demonstrate mild pain, four to six would be moderate pain, seven to nine would be severe pain and a ten would be the worst pain possible. Improvement in BPI was determined if their NRS score went down with each injection(s). (NCT03028012)
Timeframe: Pre-Injection and Three Month Post Injection(s)
| Intervention | score on a scale (Number) | |||
|---|---|---|---|---|
| Participant Number 3 at Baseline | Participant Number 3 at 3 Months | Participant Number 8 at Baseline | Participant Number 8 at 3 Months | |
| Ketorolac | 8 | 3 | 5 | 3 |
2 reviews available for lidocaine and Fibromyalgia
| Article | Year |
|---|---|
Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain.
Topics: Anesthetics, Local; Exercise Therapy; Fibromyalgia; Humans; Hyperalgesia; Lidocaine; Muscle, Skeleta | 2010 |
[Pharmacological pain analysis as diagnostic and therapeutic help].
Topics: Adenosine; Analgesics, Opioid; Anesthetics, Local; Animals; Fibromyalgia; Humans; Ketamine; Lidocain | 1998 |
15 trials available for lidocaine and Fibromyalgia
| Article | Year |
|---|---|
Granisetron vs. lidocaine injection to trigger points in the management of myofascial pain syndrome: a double-blind randomized clinical trial.
Topics: Fibromyalgia; Granisetron; Humans; Lidocaine; Myofascial Pain Syndromes; Trigger Points | 2021 |
Low-level laser therapy and anesthetic infiltration for orofacial pain in patients with fibromyalgia: a randomized clinical trial.
Topics: Anesthesia, Local; Anesthetics, Local; Facial Pain; Female; Fibromyalgia; Humans; Lasers, Semiconduc | 2018 |
Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Female; Fibromyalgia; Humans; Hyperalgesia; Injectio | 2014 |
Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study.
Topics: Administration, Intravenous; Adult; Amitriptyline; Anesthetics, Local; Biomarkers; Brazil; Double-Bl | 2016 |
Intravenous lidocaine for fibromyalgia syndrome: an open trial.
Topics: Adult; Anesthetics, Local; Female; Fibromyalgia; Health Status; Humans; Infusions, Intravenous; Lido | 2009 |
Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Afferent Pathways; Analysis of Variance; Anesthetics, Local; Arm; Double-Blind Method; Female | 2009 |
Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia.
Topics: Adolescent; Adult; Amitriptyline; Analgesics; Catecholamines; Dopamine; Double-Blind Method; Drug Th | 2011 |
Intramuscular and nerve root stimulation vs lidocaine injection to trigger points in myofascial pain syndrome.
Topics: Aged; Anesthetics, Local; Electric Stimulation Therapy; Female; Fibromyalgia; Humans; Injections, In | 2007 |
The use of topical 4% lidocaine in spheno-palatine ganglion blocks for the treatment of chronic muscle pain syndromes: a randomized, controlled trial.
Topics: Administration, Topical; Adult; Anxiety; Autonomic Nerve Block; Chronic Disease; Depression; Double- | 1995 |
Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.
Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Double-Blind Method; Femal | 1995 |
Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.
Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Double-Blind Method; Femal | 1995 |
Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.
Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Double-Blind Method; Femal | 1995 |
Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.
Topics: Adult; Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Double-Blind Method; Femal | 1995 |
Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Drug Combinations; Female; Fibromyalgia; Humans; Lid | 1995 |
Botulinum toxin is unsatisfactory therapy for fibromyalgia.
Topics: Botulinum Toxins; Double-Blind Method; Female; Fibromyalgia; Humans; Injections, Intramuscular; Lido | 1996 |
Intravenous lignocaine in the management of primary fibromyalgia syndrome.
Topics: Adult; Aged; Anesthetics, Local; Female; Fibromyalgia; Humans; Infusions, Intravenous; Lidocaine; Mi | 1995 |
Fibromyalgia--are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs.
Topics: Adult; Anesthetics, Dissociative; Area Under Curve; Cross-Over Studies; Double-Blind Method; Drug Th | 1997 |
Sphenopalatine blocks in the treatment of pain in fibromyalgia and myofascial pain syndrome.
Topics: Anesthetics, Local; Autonomic Nerve Block; Double-Blind Method; Female; Fibromyalgia; Follow-Up Stud | 1997 |
15 other studies available for lidocaine and Fibromyalgia
| Article | Year |
|---|---|
Repeated Intravenous Lidocaine Infusions for Patients with Fibromyalgia: Higher Doses of Lidocaine Have a Stronger and Longer-Lasting Effect on Pain Reduction.
Topics: Anesthetics, Local; Fibromyalgia; Humans; Infusions, Intravenous; Lidocaine; Pain; Pain Measurement; | 2020 |
Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients.
Topics: Abdominal Pain; Adult; Aged; Anesthetics, Local; Female; Fibromyalgia; Humans; Lidocaine; Male; Midd | 2018 |
Usefulness of K-Point Injection for the Nonspecific Neck Pain in So-Called K-Point Syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Local; Dexamethasone; Female; Fibromyalgia; Humans; Inj | 2016 |
Spotting the pain in fibromyalgia syndrome--widespread effects of local pain therapy.
Topics: Anesthetics, Local; Arthralgia; Facial Pain; Fibromyalgia; Humans; Lidocaine; Pain; Syndrome; Treatm | 2011 |
Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus.
Topics: Anesthetics, Local; Animals; Case-Control Studies; Chronic Pain; Disease Models, Animal; Female; Fib | 2012 |
Adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.
Topics: Adult; Aged; Female; Fibromyalgia; Humans; Hypertension, Pulmonary; Hypotension; Infusions, Intraven | 2003 |
[EXPLORATION OF THE SENSORY FUNCTION OF THE UPPER LIMB AND OF THE CORRELATED CUTANEOUS PHENOMENA IN FIBROMYALGIAS. EFFECTS OF BLOCKING OF THE SENSORY PATHWAYS AND STELLATE GANGLION].
Topics: Arm; Autonomic Nerve Block; Electrophysiology; Fibromyalgia; Humans; Lidocaine; Muscular Diseases; P | 1963 |
Primary fibromyalgia.
Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Fibromyalgia; Humans; Lidocaine; M | 1982 |
Localized fibromyalgia in a child.
Topics: Adolescent; Anesthetics, Local; Anti-Inflammatory Agents; Fibromyalgia; Humans; Lidocaine; Male; Met | 1995 |
Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
Topics: Adult; Anesthetics, Local; Female; Fibromyalgia; Humans; Injections, Intramuscular; Lidocaine; Middl | 1996 |
Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
Topics: Adult; Anesthetics, Local; Female; Fibromyalgia; Humans; Injections, Intramuscular; Lidocaine; Middl | 1996 |
Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
Topics: Adult; Anesthetics, Local; Female; Fibromyalgia; Humans; Injections, Intramuscular; Lidocaine; Middl | 1996 |
Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia.
Topics: Adult; Anesthetics, Local; Female; Fibromyalgia; Humans; Injections, Intramuscular; Lidocaine; Middl | 1996 |
Injection of steroids in painful breasts.
Topics: Adult; Drug Combinations; Female; Fibromyalgia; Humans; Injections; Lidocaine; Mastitis; Middle Aged | 1977 |
Arthrography can help free 'frozen shoulder'.
Topics: Fibromyalgia; Humans; Injections, Intra-Articular; Iothalamate Meglumine; Lidocaine; Radiography; Sh | 1979 |
Primary fibromyalgia.
Topics: Administration, Topical; Anti-Inflammatory Agents; Arthritis; Chlorofluorocarbons, Methane; Diagnosi | 1985 |
Triggerpoints.
Topics: Fibromyalgia; Humans; Injections, Intramuscular; Lidocaine; Muscle Cramp; Muscle Rigidity; Muscles | 1973 |
Stiff muscles and bony tendons.
Topics: Adult; Affective Symptoms; Amobarbital; Diazepam; Dihydroxyphenylalanine; Electromyography; Female; | 1970 |